For the third time in the past four weeks, stocks within the medtech industry climbed to never-before-seen heights as 2021 reared its head. Previous highs have largely been a result of the FDA granting Moderna emergency use authorization for its vaccine candidate and its subsequent rollout to the U.S., joining the one made by Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX), […]
Olympus
Olympus acquires Veran Medical Technologies
Olympus (TYO:7733) today said it acquired Veran Medical Technologies for $340 million. St. Louis, Mo.-based Veran Medical Technology makes medical devices specializing in interventional pulmonology. Through the deal, Olympus will gain Veran’s global sales network, marketing, manufacturing, R&D and other function to expand its respiratory product portfolio. “We are very excited about the synergies this acquisition […]
Olympus warns on endoscope infection risk
Olympus (TYO:7733) is advising healthcare providers to inspect certain ultrasound endoscopes before using them due to the potential for patient infection. The global recall covers 8,522 devices distributed in the U.S., according to FDA records. In an urgent field safety notice, the company listed 23 models of endoscopes that might contain residual blood and foreign matter […]
How did medtech companies score on environmental stewardship list?
Medical Design & Outsourcing recently rated the world’s largest medical device companies — the Big 100 — for their sales numbers and R&D spend. Now we can share how some of them scored on an environmental nonprofit’s annual list of companies ranked for their actions on climate change. Not-for-profit organization CDP (Stockholm, Sweden) runs a global disclosure system for […]
MedTech 100: New heights reached once again
Nearly a month after reaching a new high mark, the medtech industry once again shot up to reach another peak in its mid-pandemic rebound. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 100.75 (Dec. 4), marking a 2.6% uptick from the 98.23 points registered […]
Olympus buys Veran Technologies for $340M
Olympus (TYO:7733) announced today that it entered into an agreement to acquire Veran Medical Technologies for up to $340 million. St. Louis, Mo.-based Veran Medical develops advanced medical devices specializing in interventional pulmonology, including navigation products to develop solutions for improved diagnosis of peripheral lung cancer, according to a news release. The acquisition by Olympus is […]
Olympus gains 510(k) clearance for colonoscopes
Olympus (TYO:7733) announced that it has received FDA 510(k) clearance for its PCF-H190T and PCF-HQ190 colonoscopes. Center Valley, Pa.-based Olympus’ two newly cleared colonoscopes provide an extension to the existing capabilities of physicians to diagnose and treat disorders of the gastrointestinal tract, according to a news release. PCF-H190TL/I is a slim, short-bending scope designed for tighter […]
Olympus announces new endoscope reprocessing technology
Olympus (TYO:7733) announced today that it launched its OER-Elite next-generation automated endoscope reprocessor (AER) on the market. Center Valley, Pa.-based Olympus’ OER-Elite is designed to simultaneously clean and disinfect up to two endoscopes in 28 minutes with Acecide-C, a peracetic, acid-based disinfectant. It also includes a cleaning cycle with a combination of EndoQuick alkaline detergent and […]
Olympus to acquire Arc Medical Design
Olympus (TYO:7733) recently announced that it has signed a definitive agreement to acquire Arc Medical Design for an undisclosed amount. Through the agreement, Olympus will acquire the company and obtain full rights to its suite of innovative medical products. It will convert its exclusive distribution rights of Endocuff Vision to a full acquisition of the product […]
Olympus launches Evis X1 endoscopy system
Olympus today said it launched its Evis X1 endoscopy system. Evis X1 is designed to improve outcomes from disorders of the stomach, colon and esophagus as well as various bronchial diseases. It features easy-to-use technologies to support how gastrointestinal disorders like colorectal cancer (CRC) are detected, characterized and treated. The system features extended depth of […]
Olympus lands FDA de Novo approval for benign hyperplasia device
Olympus (TYO:7733) announced today that it received FDA de Novo classification for its iTind non-surgical device for treating benign prostatic hyperplasia (BPH). Israel-based medical device manufacturer Medi-Tate originally designed the iTind device. Olympus holds the exclusive right to distribute Medi-Tate products in the U.S. through a strategic investment. The iTind is designed as a flexible, three-strut […]
